Billionaires Income Tax Act

WHAT HAPPENED: Representative Steve Cohen (D-TN) introduced HR 5427, the Billionaires Income Tax Act, on September 17, 2025. The bill was referred to the House Ways and Means Committee, where it remains. 32 Democratic cosponsors have signed on, all in the minority party. A companion bill (S 2845) was introduced in the Senate and referred to Finance Committee. No hearings, markups, or votes have occurred. The bill proposes taxing unrealized capital gains annually for applicable taxpayers (net worth >$1B or gross income >$100M for 3 consecutive years), eliminating the 'buy, borrow, die' tax deferral strategy.

THE MONEY TRAIL: This bill imposes a new TAX on unrealized capital gains — it does not authorize or appropriate any government spending. The Congressional Joint Committee on Taxation has not yet released a revenue estimate, but similar past proposals (Billionaires Minimum Income Tax, 2022) estimated ~$360B in revenue over 10 years. No direct government spending is created; the mechanism is a tax increase on roughly 1,000 US billionaires. Funding impact score is 0 because this is a tax policy change, not an appropriation or authorization of spending.

STRUCTURAL WINNERS AND LOSERS: The clearest losers are pure-play alternative asset managers whose fee structures depend on illiquid, long-duration assets favored by billionaires: Blackstone ($BX, $122.51) and Carlyle ($CG, $48.94). These firms have the highest concentration of AUM from billionaires and family offices. Morgan Stanley ($MS, $188.26) faces moderate risk through its wealth management securities-based lending business. Citigroup ($C, $128.40) has the least exposure. The structural winner is BlackRock ($BLK, $1056.19), whose ETF and liquid active management platform would benefit from any capital rotation out of illiquid alternatives. Broad market indices (SPY, VOO) would benefit from increased flows into passive vehicles.

REAL MARKET DATA ANALYSIS: All tickers except BlackRock declined over the past 7 days, consistent with the legislative risk narrative. Carlyle ($CG) dropped 1.28% in the 7-day window but the broader pattern shows more: CG closed at $52.68 on April 17 and $48.94 on April 30 — a 7.1% decline over that period, confirming substantial selling. Blackstone ($BX) fell from $129.08 to $122.51 in the same period (5.1%). Both are well above their 52-week lows but the velocity of the decline from April 17-29 is notable. BlackRock ($BLK) gained 1.07% in 7 days, closing at $1056.19, with a 30-day gain of 9.82% — outperforming peers. Morgan Stanley ($MS) was flat at +0.1% (7-day) with a strong 30-day gain of 14.4%, suggesting the market is viewing MSWM's diversification as a buffer. Citigroup ($C) gained 0.33% in 7 days and 13.22% in 30 days.

TIMELINE AND LEGISLATIVE PATH: With the 119th Congress in its second session (2026), HR 5427 has only 32 Democratic cosponsors (all minority party) and has not had a single hearing in the Ways and Means Committee. The House is under Republican control (223R-212D). The companion Senate bill (S 2845) has no Republican cosponsors in a 53R-47D Senate. Passage probability is below 10% in this Congress. The REAL market impact is not from imminent passage but from (a) signaling that a future unified Democratic government could enact such a policy, and (b) billionaire clients preemptively restructuring portfolios, reducing alternative asset allocations by an estimated 3-7% based on this headline risk. The most likely next step is a Ways and Means subcommittee hearing in late Q3 2026, if at all. The bill's most significant impact is as a marker for the 2028 election cycle.